In conclusion, our findings suggest that MAPK8IP1P2 may serve as a potential biomarker to predict lymphatic metastasis in thyroid cancer, or a potential therapeutic target in lymphatic metastatic thyroid cancer. The gene discussed is MAPK8IP1P2; the disease is thyroid gland carcinoma.